Futures are pointing to a lower Wall Street open, with China ramping up its rhetoric in the ongoing trade dispute with the U.S.Morning Briefread more
A Ministry of Commerce spokesperson did not mention any U.S. actions specifically, but it's been a tense couple of weeks for the trade negotiations.World Politicsread more
U.S. stock index futures were sharply lower Thursday as U.S.-China trade worries persisted with more companies suspending business with Chinese telecom giant Huawei.US Marketsread more
British Prime Minister Theresa May could announce her resignation in the next few days, according to U.K. media reports, as she faces increasing pressure from members of her...Europe Politicsread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
With Tesla shares skidding, two experts weigh in on what could be next for the automaker and its volatile stock.Trading Nationread more
Chinese government-aligned experts are stressing that the U.S. will need to negotiate a trade agreement with Asia's largest economy.China Economyread more
Under-the-radar hedge-fund managers beating the market are betting on big comeback stories General Electric and PG&E, as well as Biogen.Marketsread more
Richard Yu, CEO of Huawei's consumer business, said Huawei's own operating system for smartphones and laptops could be ready for use in China by fall this year.Technologyread more
Best Buy beat Wall Street estimates for quarterly same-store sales on Thursday, as the consumer electronics retailer sold more wearables and tablets and signed up more people...Retailread more
Shares of L Brands, the owner of Victoria's Secret and Bath & Body Works, rose nearly 11% in aftermarket trading Wednesday after the company reported it beat revenue and...Retailread more
The Senate confirmed the nomination of former drug company executive Alex Azar as head of the U.S. Health and Human Services Department on Wednesday.
Azar's long-expected approval as HHS secretary puts him in a charge of a department with a trillion-dollar budget that oversees the massive Medicare and Medicaid health coverage systems, drug regulatory bodies, disease-fighting agencies and the ever-controversial Obamacare health reform law.
The Senate voted 55-43 in favor of Azar's appointment.
The 50-year-old Azar is a veteran of HHS, having served for two years as deputy secretary and before that as general counsel of the department, both during the administration of President George W. Bush.
In 2017, the Yale Law grad ended a five-year stint as president of the U.S. division of pharmaceuticals giant Eli Lilly and Co.
Democratic senators during Azar's recent confirmation hearings highlighted the price increases of Lily's drugs while he was at the company, and given that history were skeptical of his claims to intend to fight rising drug costs as HHS chief.
Azar is the first person with a pharmaceutical industry background to lead the health agency.
And two former HHS chiefs under Bush, Tommy Thompson and Mike Leavitt, wrote in The Hill that Azar "has the necessary experience, skills, motivation and integrity" to run the department.
HHS had been without a secretary since September, when Trump's original pick for the job, Dr. Tom Price, resigned amid controversy over his use of private and expensive charter jets for official travel.
Price's departure came while Trump and his Republican allies in Congress were pushing legislation that sought to repeal and replace key parts of the Affordable Care Act, as Obamacare is formally known.
Those efforts failed, repeatedly, in the Senate. But the recently passed tax law did effectively eliminate, starting in 2019, the ACA requirement that most Americans have some form of Obamacare-compliant health coverage or pay a fine.
Azar opposes the ACA, which has led to criticism of his nomination from groups that support Obamacare.
On Wednesday, The Washington Post reported that the Trump administration is looking into expanding access to hardship exemptions from Obamacare's coverage mandate, making it easier for people to avoid the existing penalty for not having insurance.
Azar, who also clerked for late conservative Supreme Court Justice Antonin Scalia, also has contributed to politicians who oppose abortion rights.
After the Senate Finance Committee voted Tuesday to advance Azar's nomination to the full Senate, the abortion rights group NARAL Pro-Choice blasted the move.
"It is sad, but not surprising, that Donald Trump is so desperate to install another anti-choice ideologue at HHS, an agency that's critical for women's healthcare. HHS has a duty to protect the health, rights, and reproductive freedom of women all across America, and Azar's clear and consistent anti-choice record should disqualify him from such an influential position," said NARAL spokeswoman Kaylie Hanson Long.